SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Sick Visit — Jacqueline du Pré — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Jacqueline Mary du Pré |
|---|
| Date of birth | 1945-01-26 |
|---|
| Identifiers | MRN HR-ML039-SYN-TD; SSN (made up) 000-39-7062 |
|---|
| Document date | 1973-06-15 |
|---|
| Author | Imogen Thackeray-Osei, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Chief Complaint
Burning on passing urine and frequency for two days, with the tingling in her fingers back. [S]
History of Present Illness
Ms. du Pré called the clinic on the second day of burning on passing urine, frequency and urgency, and was seen the same day. Since yesterday she has felt feverish (37.8 °C at home) and the tingling in the fingers of her left hand, which had almost gone, has come back, with the fingers feeling a little clumsy on the fingerboard this morning. There is no new weakness, no unsteadiness, no change in vision and no back or loin pain. She has had no vaginal discharge and her last period was two weeks ago. She completed the first ocrelizumab course seven weeks ago. She is afraid this is a new relapse and asked whether she needs steroids again. She has had no thoughts of self-harm. [S]
| Element | Detail |
|---|
| Onset | Two days ago |
| Severity | Burning, frequency and urgency; low fever; no loin pain |
| Context | Seven weeks after the first ocrelizumab course; infections are more common on anti-CD20 therapy |
| Associated signs and symptoms | Old tingling in the left fingers returned with the fever; no new deficit |
Review of Systems
| System | Result | Finding |
|---|
| Constitutional | Positive | Feverish and tired since yesterday |
| Genitourinary | Positive | Burning, frequency and urgency; no blood in the urine, no discharge, no loin pain |
| Neurological | Positive | Returning tingling in the left fingers since the fever; no new weakness, imbalance or visual change |
| Gastrointestinal | Negative | No vomiting, diarrhea or abdominal pain |
| Musculoskeletal | Negative | No back pain |
| Psychiatric | Negative | Worried about a relapse; no thoughts of self-harm |
6 systems reviewed. [S]
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Nitrofurantoin macrocrystals 100 mg oral capsule, one capsule by mouth twice daily with food for 5 days | One capsule twice daily for 5 days | Oral route | 1973-06-15 to 1973-06-19 | completed | S |
| Methylprednisolone 1000 mg injection, 1 g intravenously over one hour once daily for 3 days | 1 g daily for 3 days | Intravenous route | 1973-03-24 to 1973-03-26 | completed | S |
| Cholecalciferol (vitamin D3) 4000 unit (100 microgram) oral capsule, one capsule by mouth daily | One capsule daily | Oral route | 1973-03-23 | active | S |
| Ocrelizumab 30 mg/mL injection: first dose as 300 mg intravenously on day 1 and day 15, then 600 mg intravenously every 6 months, with methylprednisolone 100 mg, an antihistamine and acetaminophen before each infusion | 300 mg on days 1 and 15, then 600 mg every 6 months | Intravenous route | 1973-04-13 | active | S |
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 1973-06-15 | Body height | 173 | cm | S |
| 1973-06-15 | Body weight | 63.6 | kg | S |
| 1973-06-15 | Body mass index (BMI) [Ratio] | 21.3 | kg/m2 | S |
| 1973-06-15 | Systolic blood pressure | 116 | mm[Hg] | S |
| 1973-06-15 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1973-06-15 | Heart rate | 92 | /min | S |
| 1973-06-15 | Respiratory rate | 16 | /min | S |
| 1973-06-15 | Body temperature | 37.8 | Cel | S |
| 1973-06-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1973-06-15 | Leukocytes [#/volume] in Blood by Automated count | 10.2 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1973-06-15 | C reactive protein [Mass/volume] in Serum or Plasma | 14 | mg/L | <=5 mg/L | High | S |
Physical Exam
Vital signs recorded on 1973-06-15; see the Vital Signs section. [S]
| System | Finding |
|---|
| General | Well, a little flushed; temperature 37.8 °C; pulse 92 |
| Abdomen | Mild suprapubic tenderness; no loin tenderness |
| Neurological | Unchanged from the last visit: light touch and vibration slightly reduced in the left fingertips, joint position normal, strength and reflexes as before, gait normal; no new sign |
| Skin | No rash |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Numbness, tingling and loss of position sense in the fingers of both hands for three weeks, worse on the left, with clumsiness that makes her lose her place on the fingerboard, an electric feeling down the spine on bending the neck (Lhermitte's sign), and fatigue; a similar month of tingling in the fingers 18 months ago settled on its own. A lesion of the cervical spinal cord must be found: MRI of the brain and spine with contrast booked this week | resolved | confirmed |
R20.2 | S — Synthetic presenting problem anchored to her documented loss of sensation in her fingers and fatigue. Superseded by the diagnosis at the second visit. |
| Relapsing-remitting multiple sclerosis, active: a current relapse (partial cervical myelitis at C3 to C4 with sensory loss and clumsiness of the hands) after an earlier sensory episode; dissemination in space and time on MRI, with an enhancing cord lesion and an enhancing brain lesion; CSF-specific oligoclonal bands; aquaporin-4 antibody negative; meets the 1964 McDonald criteria and the 1971 revision; synthetic modern detail linked to her documented diagnosis | active | confirmed |
G35.A | S — Synthetic course, imaging and laboratory detail; linked to her documented diagnosis in October 1973. |
| Vitamin D deficiency: 25-hydroxyvitamin D 16 ng/mL; replacement to correct the deficiency, not as a treatment for multiple sclerosis | active | confirmed |
E55.9 | S — Synthetic finding. |
| Acute uncomplicated cystitis (Escherichia coli) seven weeks after the first ocrelizumab course, with a pseudo-relapse: two days of returning tingling in the fingers with a low fever and no new neurological deficit; resolved | active | confirmed |
N30.00 | S — Synthetic intercurrent infection; not a historical claim. |
Assessment and Plan
- Acute uncomplicated cystitis with a pseudo-relapse (N30.00). Acute cystitis: the dipstick shows leukocyte esterase and nitrites, and the culture later grew Escherichia coli sensitive to nitrofurantoin; white cells 10.2 and CRP 14 mg/L. There is no loin pain and the fever is low, so this is not pyelonephritis. The return of old tingling with a fever and no new sign is a pseudo-relapse, caused by the infection and the raised temperature acting on an old lesion, not new inflammation, so steroids are not needed. [S]
- Nitrofurantoin 100 mg twice daily for 5 days.
- Plenty of fluids; acetaminophen for fever.
- If the tingling has not settled within a day or two of the fever going, or any new symptom appears, call: that would need a neurological review and MRI.
- Call at once for loin pain, rigors or vomiting.
- Relapsing-remitting multiple sclerosis on ocrelizumab (G35.A). First course completed seven weeks ago; hand function had nearly recovered before this illness. [S]
- Re-baseline MRI and review in four weeks, as booked.
Guideline basis: Multiple sclerosis in adults: management (NICE guideline NG220) (2022); Gupta K, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the IDSA and ESCMID. Clin Infect Dis 2011;52(5):e103-e120 (PMID 21292654) (2011)
Follow-up: Phone call in two days. Review with the re-baseline MRI in four weeks. Call for loin pain, high fever or any new neurological symptom. Next scheduled visit 1973-07-13: three months on ocrelizumab: re-baseline MRI, B-cell depletion, fatigue, vitamin D and hand function. [S]